Skip to main navigation Skip to search Skip to main content

The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer

  • Jing Li
  • , Dianbao Zhang
  • , Zhiwei Liu
  • , Yukun Wang
  • , Xinyang Li
  • , Ziming Wang
  • , Gaofeng Liang
  • , Xiang Yuan
  • , Yuanpei Li
  • , Andrzej L Komorowski
  • , Warren Matthew Rozen
  • , Armando Orlandi
  • , Kazuaki Takabe
  • , Gianluca Franceschini
  • , Guy Jerusalem
  • , Xinshuai Wang

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)83-83
Number of pages1
JournalAnnals of Translational Medicine
Volume11
DOIs
Publication statusPublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • PD-L1 inhibitor
  • Triple-negative breast cancer (TNBC)
  • anlotinib
  • apoptosis
  • treatment

Cite this